Ben Izizag Bepouka
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Madone Mandina
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Jean Robert Makulo
Unit of Nephrology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Murielle Longokolo
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Ossam Odio
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Nadine Mayasi
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Tresor Pata
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Godelive Nsangana
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Felly Tshikangu
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Donatien Mangala
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Dupont Maheshe
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Serge Nkarnkwin
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Jonathan Muamba
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Gorby Ndaie
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Rodrigue Ngwizani
Unit of Reanimation, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Yves Yanga
Unit of Reanimation, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Aliocha Nkodila
Unit of Vaccinology, World Health Organization, Kinshasa, Democratic Republic of the Congo
Hervé Keke
Department of Epidemiology, Ministry of Health, Kinshasa, Democratic Republic of the Congo
Yamin Kokusa
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Francois Lepira
Unit of Nephrology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Innocent Kashongwe
Unit of Pneumology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Marcel Mbula
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Jean Marie Kayembe
Unit of Pneumology, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Hippolyte Situakibanza
Unit of Infectious Diseases, Kinshasa University Hospital, Kinshasa, Democratic Republic of the Congo
Abstract
Introduction: since the 1st case of coronavirus disease 2019 (COVID-19) in Kinshasa on March 10th 2020, mortality risk factors have not yet been reported. The objectives of the present study were to assess survival and to identify predictors of mortality in COVID-19 patients at Kinshasa University Hospital.
Methods: a retrospective cohort study was conducted, 141 COVID-19 patients admitted at the Kinshasa University Hospital from March 23 to June 15, 2020 were included in the study. Kaplan Meier's method was used to described survival. Predictors of mortality were identified by COX regression models.
Results: of the 141 patients admitted with COVID-19, 67.4 % were men (sex ratio 2H:1F); their average age was 49.6±16.5 years. The mortality rate in hospitalized patients with COVID-19 was 29% during the study period with 70% deceased within 24 hours of admission. Survival was decreased with the presence of hypertension, diabetes mellitus, low blood oxygen saturation (BOS), severe or critical stage disease. In multivariate analysis, age between 40 and 59 years [adjusted Hazard Ratio (aHR): 4.07; 95% CI: 1.16 - 8.30], age at least 60 years (aHR: 6.65; 95% CI: 1.48-8.88), severe or critical COVID-19 (aHR: 14.05; 95% CI: 6.3-15.67) and presence of dyspnea (aHR: 5.67; 95% CI: 1.46-21.98) were independently and significantly associated with the risk of death.
Conclusion: older age, severe or critical COVID-19 and dyspnea on admission were potential predictors of mortality in patients with COVID-19. These predictors may help clinicians identify patients with a poor prognosis.